EP 2779995 A1 20140924 - IMMEDIATE RELEASE 4-METHYL-3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]-N-[5-(4-METHYL- 1H-IMIDAZOL-1-YL)-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE FORMULATION
Title (en)
IMMEDIATE RELEASE 4-METHYL-3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]-N-[5-(4-METHYL- 1H-IMIDAZOL-1-YL)-3-(TRIFLUOROMETHYL)PHENYL]BENZAMIDE FORMULATION
Title (de)
4-METHYL-3- [[4- (3-PYRIDINYL)] -2-PYRIMIDINYL]AMINO] -N- [5- (4-METHYL-1H-IMIDAZOL- 1-YL)-3-(TRIFLUORMETHYL)PHENYL]BENZAMIDFORMULIERUNG MIT UNMITTELBARER FREISETZUNG
Title (fr)
FORMULATION À LIBÉRATION IMMÉDIATE DE 4-MÉTHYL-3-[[4-(3-PYRIDINYL)-2-PYRIMIDINYL]AMINO]-N-[5-(4-MÉTHYL- 1H-IMIDAZOL-1-YL)-3-(TRIFLUOROMÉTHYL)PHÉNYL]BENZAMIDE
Publication
Application
Priority
- US 201161559281 P 20111114
- US 2012064610 W 20121112
Abstract (en)
[origin: WO2013074432A1] A solid dosage form of nilotinib is disclosed that comprises: (i) a core comprising 4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl] benzamide or a pharmaceutically acceptable salt thereof and excipients; and (ii) at least one polymer, said polymer coating said core, wherein disintegration of said solid dosage form is delayed.
IPC 8 full level
A61K 9/00 (2006.01); A61K 9/20 (2006.01); A61K 9/28 (2006.01)
CPC (source: EP)
A61K 9/2054 (2013.01); A61K 9/2095 (2013.01); A61K 9/2866 (2013.01); A61K 31/506 (2013.01); A61P 35/00 (2017.12); A61P 35/02 (2017.12)
Citation (search report)
See references of WO 2013074432A1
Citation (examination)
"Rote Liste 2009", 2 January 2009, ROTE LISTE SERVICE GMBH, article UNKNOWN: "Tasigna", pages: 86192, XP055432849
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
DOCDB simple family (publication)
WO 2013074432 A1 20130523; AR 088844 A1 20140710; AU 2012339829 A1 20140529; AU 2012339829 B2 20160512; BR 112014011518 A2 20170516; CA 2855503 A1 20130523; CL 2014001247 A1 20141017; CN 103930094 A 20140716; CO 6960546 A2 20140530; EA 201490960 A1 20140829; EP 2779995 A1 20140924; GT 201400094 A 20170928; HK 1197025 A1 20150102; IL 232480 A0 20140630; IN 3416DEN2014 A 20150626; JP 2014533283 A 20141211; JP 6275645 B2 20180207; KR 20140093230 A 20140725; MA 35636 B1 20141101; MX 2014005874 A 20140623; NZ 623844 A 20160930; PE 20141337 A1 20141016; SG 10201707768R A 20171030; SG 11201401476T A 20141030; TN 2014000177 A1 20150930; TW 201325594 A 20130701; TW I574690 B 20170321; ZA 201402756 B 20150429
DOCDB simple family (application)
US 2012064610 W 20121112; AR P120104259 A 20121112; AU 2012339829 A 20121112; BR 112014011518 A 20121112; CA 2855503 A 20121112; CL 2014001247 A 20140513; CN 201280055937 A 20121112; CO 14103891 A 20140514; EA 201490960 A 20121112; EP 12798500 A 20121112; GT 201400094 A 20140514; HK 14110470 A 20141021; IL 23248014 A 20140505; IN 3416DEN2014 A 20140429; JP 2014541363 A 20121112; KR 20147012521 A 20121112; MA 36991 A 20140507; MX 2014005874 A 20121112; NZ 62384412 A 20121112; PE 2014000672 A 20121112; SG 10201707768R A 20121112; SG 11201401476T A 20121112; TN 2014000177 A 20140425; TW 101142278 A 20121113; ZA 201402756 A 20140415